HRA004591
Title:
The differential transcriptomics of taxol resistant cancer cells with shEREG or ASIV treatment
Release date:
2025-05-14
Description:
To investigate the whether ASIV treatment has a similar effect on transcriptomics with shEREG,we established A549-TR cell lines with shEREG virus. We then performed gene expression profiling analysis using data obtained from RNA-seq of A549-TR or shEREG-A549-TR cells treated with ASIV for 48 hours.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cell line related study
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
drug resistance of cancer
Contact person:
Xu Wei
Email:
wei-xu11@tsinghua.org.cn
Description:
We collected the raw datas about RNA-seq or proteomics from cancer cell lines or clinical cancer sample, which was applied to illustrate the mechanism of drug resistance.
Individuals & samples
Submitter:   Xu Wei / wei-xu11@tsinghua.org.cn
Organization:   Shanghai university of traditional chinese medicine
Submission date:   2023-05-16
Requests:   -